Search results
Eduardo Bosch-Peligero
Author
Author(s):
Erin D Michos
Added:
1 year ago
What are the lipid highlights from ACC.22?
In this insightful review, Dr Erin Michos (Johns Hopkins University School of Medicine, Baltimore, MD, US) talks about selected ACC.22 late-breaking clinical trials highlighting the take-home messages for clinical practice.
Trials covered in detail include:
00:28: APOLLO Trial: Magnitude and Duration of Effects of a Short-interfering RNA Targeting…
View more
Author(s):
Anne H Tavenier
,
Johny Nicolas
,
Roxana Mehran
Added:
1 year ago
Oliver Weingärtner
Author
Author(s):
Erin A Bohula
Added:
5 years ago
Dr Erin Bohula (Brigham and Women's Hospital, Boston, US) discusses CAMELLIA-TIMI 61 - a study to evaluate the effect of long-term treatment with BELVIQ (Lorcaserin HCl) on the incidence of MACE and conversion to type 2 diabetes mellitus in obese and overweight subjects with CVD or multiple CV risk factors.
Filmed on-site at ESC 2018.
View more
Cardio-oncology A-Z
Video Series
Thomas A Haffey
Author
Author(s):
Harriette Van Spall
,
Deepak L Bhatt
Added:
3 years ago
Dr Harriette Van Spall (McMaster University, Hamilton, CA) and Dr Deepak L Bhatt (Brigham and Women's Hospital, Boston, MA, US) discuss the results and implications of the SCORED trial. Dr Van Spall asks about the change the original endpoints of the trial in light of the evolving knowledge on the SGLT2i class and the impact of the COVID19 pandemic. Dr Bhatt and Dr Van Spall reviews the patient…
View more
Author(s):
Marc S Sabatine
Added:
1 year ago
In this video, Dr Marc S Sabatine addresses the context of theFOURIER-OLElong-term trial and how it impacts the current treatment paradigm. It also reports on what impact this extension study has on the guideline directed LDL-C targets and what this means for the use of PCSK-9 inhibitors.
This video is part of a series of interviews, recorded at ESC Congress 2022 in Barcelona, in which Dr…
View more
Sergio Baptista
Author